MedTrace Logo

Resection of Colorectal Liver Metastases With or Without Routine Hilar Lymphadenectomy

NCT01073358 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 166

Last updated 2017-10-27

No results posted yet for this study

Summary

It is uncertain, whether hilar lymphadenectomy should be performed routinely in patients undergoing resection of colorectal liver metastases.

For this reason it is the aim of the present prospective randomized trial to evaluate, if routine lymphadenectomy reduces recurrent disease in patients undergoing resection of colorectal liver metastases.

Conditions

Interventions

PROCEDURE

Routine hilar lymphadenectomy

Hilar lymphadenectomy is performed before actual resection of the colorectal liver metastases

Sponsors & Collaborators

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Jürgen Weitz, MD, MSc · Department of Gastrointestinal, Thoracic and Vascular Surgery Dresden

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-09
Primary Completion
2019-07-31
Completion
2021-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01073358 on ClinicalTrials.gov